FENOFIBRIC ACID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fenofibric Acid, and what generic alternatives are available?
Fenofibric Acid is a drug marketed by Actavis Elizabeth, Alembic, Anchen Pharms, Aurobindo Pharma Ltd, Chartwell Rx, Graviti Pharms, Impax Labs Inc, Macleods Pharms Ltd, Micro Labs, Mylan Pharms Inc, Twi Pharms, and Yichang Humanwell. and is included in twelve NDAs.
The generic ingredient in FENOFIBRIC ACID is choline fenofibrate. There are one hundred and two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the choline fenofibrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FENOFIBRIC ACID?
- What are the global sales for FENOFIBRIC ACID?
- What is Average Wholesale Price for FENOFIBRIC ACID?
Summary for FENOFIBRIC ACID
US Patents: | 0 |
Applicants: | 12 |
NDAs: | 12 |
Finished Product Suppliers / Packagers: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 115 |
Clinical Trials: | 21 |
Patent Applications: | 1,657 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for FENOFIBRIC ACID |
What excipients (inactive ingredients) are in FENOFIBRIC ACID? | FENOFIBRIC ACID excipients list |
DailyMed Link: | FENOFIBRIC ACID at DailyMed |
![FENOFIBRIC ACID drug patent expirations Drug patent expirations by year for FENOFIBRIC ACID](/p/graph/s/t/FENOFIBRIC_ACID-patent-expirations.png)
![Drug Prices for FENOFIBRIC ACID](/p/graph/drug-price/FENOFIBRIC+ACID.png)
US Patents and Regulatory Information for FENOFIBRIC ACID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Elizabeth | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 200920-001 | Oct 7, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Micro Labs | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 213450-002 | Jun 16, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Yichang Humanwell | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 212562-002 | Dec 23, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Aurobindo Pharma Ltd | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 212598-001 | Jul 25, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Alembic | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 208705-002 | May 12, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |